1AI 10.0% 0.9¢ algorae pharmaceuticals limited

Ann: Results of LCT Parkinsons trial require further analysis, page-114

  1. 8,751 Posts.
    lightbulb Created with Sketch. 782
    In my opinion further analysis will probably not offer too much.

    In my opinion, it appears as though one person from the NTCELL120 group did poorly and that made the NTCELL120 group look worse than the placebo group and one person from the NTCELL80 group did better than the rest and that may have made the NTCELL80 group look better than the placebo group. In my opinion if they were removed all the groups would have been very similar to the placebo group.


    LCT phase 2.png
    Last edited by retiredyoung: 11/11/17
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $15.18M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $750 83.33K

Buyers (Bids)

No. Vol. Price($)
5 206531 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 383746 1
View Market Depth
Last trade - 14.28pm 12/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.